XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive income (loss)
Non- Controlling interest
Treasury shares
Total
Balance at Dec. 31, 2019 $ 53,222 $ 14,101,689 $ 180,208,610 $ 1,230,511 $ (176,177,413) $ (1,744,730) $ 52,777 $ (4,066,610) $ 13,658,056
Balance (in Shares) at Dec. 31, 2019 53,220,902             (144,206)  
Balance at Jun. 30, 2020 $ 63,803 14,101,689 185,487,657 1,230,511 (179,734,609) (2,016,076) 56,872 $ (4,066,610) 15,123,237
Balance (in Shares) at Jun. 30, 2020 63,802,338             (144,206)  
Net income (loss) (3,557,196)   4,918 (3,552,278)
Share-based compensation for employee and director stock awards 454,096 454,096
Common stock issued to employees and directors for stock awards $ 293 (293)
Common stock issued to employees and directors for stock awards (in Shares) 293,498              
Common stock issued to investors $ 10,288 4,825,244 4,835,532
Common stock issued to investors (in Shares) 10,287,938              
Foreign currency translation adjustment (271,346) (823) (272,169)
Balance at Mar. 31, 2020 $ 53,590 14,101,689 180,708,377 1,230,511 (178,537,394) (2,045,945) 57,817 $ (4,066,610) 11,502,035
Balance (in Shares) at Mar. 31, 2020 53,588,799             (144,206)  
Balance at Jun. 30, 2020 $ 63,803 14,101,689 185,487,657 1,230,511 (179,734,609) (2,016,076) 56,872 $ (4,066,610) 15,123,237
Balance (in Shares) at Jun. 30, 2020 63,802,338             (144,206)  
Net income (loss) (1,197,215) (952) (1,198,167)
Share-based compensation for employee and director stock awards 153,961 153,961
Common stock issued to employees and directors for stock awards $ 293 (293)
Common stock issued to employees and directors for stock awards (in Shares) 293,498              
Common stock issued to investors $ 9,920 4,625,612 4,635,532
Common stock issued to investors (in Shares) 9,920,041              
Foreign currency translation adjustment 29,869 7 29,876
Balance at Dec. 31, 2020 $ 79,310 14,101,689 225,278,113 1,230,511 (183,984,311) (239,609) 7,735 $ (4,066,610) 52,406,828
Balance (in Shares) at Dec. 31, 2020 79,310,249             (144,206)  
Balance at Jun. 30, 2021 $ 88,538 14,101,689 241,141,468 1,230,511 (151,674,428) 997,013 20,355 $ (4,066,610) 101,838,536
Balance (in Shares) at Jun. 30, 2021 88,538,723             (144,206)  
Net income (loss) 32,309,883 18,508 32,328,391
Share-based compensation for employee and director stock awards 242,572 242,572
Common stock issued to employees and directors for stock awards $ 288 (288)
Common stock issued to employees and directors for stock awards (in Shares) 288,498              
Issuance of common stock and warrants $ 8,940   15,621,071           15,630,011
Issuance of common stock and warrants (in Shares) 8,939,976                
Foreign currency translation adjustment 1,236,622 (5,888) 1,230,734
Balance at Mar. 31, 2021 $ 88,250 14,101,689 241,048,002 1,230,511 (154,375,029) (145,568) 1,718 $ (4,066,610) 97,882,963
Balance (in Shares) at Mar. 31, 2021 88,250,225             (144,206)  
Balance at Jun. 30, 2021 $ 88,538 14,101,689 241,141,468 1,230,511 (151,674,428) 997,013 20,355 $ (4,066,610) 101,838,536
Balance (in Shares) at Jun. 30, 2021 88,538,723             (144,206)  
Net income (loss) 2,700,601 19,622 2,720,223
Share-based compensation for employee and director stock awards 93,754 93,754
Common stock issued to employees and directors for stock awards $ 288 (288)
Common stock issued to employees and directors for stock awards (in Shares) 288,498              
Foreign currency translation adjustment $ 1,142,581 $ (985) $ 1,141,596